SCHEMBL25870883

SCHEMBL25870883

CCN(C(=O)c1ccc(C(C)C)cc1)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.49
USP5 P45974 1/20 0.46
HSP90AA1 P07900 2/20 0.44
HSP90AB1 P08238 2/20 0.44
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.42
LMNA P02545 3/20 0.41
MAPT P10636 2/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 1/20 0.40
FASN P49327 1/20 0.40
POLB P06746 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004615 0.81 NAMPT (0.55) NAMPTHPGDLMNAMAPTMEN1
SCHEMBL4472102 0.81 HSP90AA1 (0.58) HSP90AA1HSP90AB1HPGDLMNAMAPT
SCHEMBL10169810 0.80 USP5 (0.47) NAMPTUSP5HSP90AA1HSP90AB1CYP2C9
SCHEMBL17285707 0.79 MAPT (0.65) NAMPTHPGDLMNAMAPTSMN1; SMN2
SCHEMBL13061752 0.79 KDM4E (0.47) NAMPTHPGDLMNAKMT2ASMN1; SMN2
SCHEMBL27317243 0.78 TSHR (0.56) NAMPTHSP90AA1HSP90AB1HPGDHDAC1
SCHEMBL25870885 0.77 HPGD (0.54) USP5CYP2C9HPGDLMNAMAPT
SCHEMBL21077974 0.77 USP5 (0.41) NAMPTUSP5HSP90AA1HSP90AB1CYP2C9
SCHEMBL19630575 0.76 OPRM1 (0.43) CYP2C9LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL25870881 0.76 USP5 (0.50) USP5CYP2C9HPGDLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174470-A1 COMPOUND AS A UBR BOX DOMAIN LIGAND AUTOTAC INC. (KR) 2023-06-08 US disclosed
US-20230174470-A1 COMPOUND AS A UBR BOX DOMAIN LIGAND AUTOTAC INC. (KR) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174470-A1 COMPOUND AS A UBR BOX DOMAIN LIGAND UBR4, UBQLN2, UBTF NAMPT 4319/4885USP5 59/4885HSP90AA1 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.